However, TIGIT + CD4 + T cells and TIGIT + CD56 + NK cells rates in pre-treatment tumor were not statistically significantly correlated with TRG (p > 0.05, Fig. 1h–i). The gene discussed is NCAM1; the disease is neoplasm.